Abstract:Human leukocyte antigen (HLA) is a key genetic factor conferring risk of systemic lupus erythematosus (SLE), but precise independent localization of HLA effects is extremely challenging. As a result, the contribution of specific HLA alleles and amino-acid residues to the overall risk of SLE and to risk of specific autoantibodies are far from completely understood. Here, we dissected (a) overall SLE association signals across HLA, (b) HLA-peptide interaction, and (c) residue-autoantibody association. Classical alleles, SNPs, and amino-acid residues of eight HLA genes were imputed across 4,915 SLE cases and 13,513 controls from Eastern Asia. We performed association followed by conditional analysis across HLA, assessing both overall SLE risk and risk of autoantibody production. DR15 alleles HLA-DRB1*15:01 (P = 1.4x10(-27), odds ratio (OR) = 1.57) and HLA-DQB1*06:02 (P = 7.4x10(-23), OR = 1.55) formed the most significant haplotype (OR = 2.33). Conditioned protein-residue signals were stronger than allele signals and mapped predominantly to HLA-DRB1 residue 13 (P = 2.2x10(-75)) and its proxy position 11 (P = 1.1x10(-67)), followed by HLA-DRB1-37 (P = 4.5x10(-24)). After conditioning on HLA-DRB1, novel associations at HLA-A-70 (P = 1.4x10(-8)), HLA-DPB1-35 (P = 9.0x10(-16)), HLA-DQB1-37 (P = 2.7x10(-14)), and HLA-B-9 (P = 6.5x10(-15)) emerged. Together, these seven residues increased the proportion of explained heritability due to HLA to 2.6%. Risk residues for both overall disease and hallmark autoantibodies (i.e., nRNP: DRB1-11, P = 2.0x10(-14); DRB1-13, P = 2.9x10(-13); DRB1-30, P = 3.9x10(-14)) localized to the peptide-binding groove of HLA-DRB1. Enrichment for specific amino-acid characteristics in the peptide-binding groove correlated with overall SLE risk and with autoantibody presence. Risk residues were in primarily negatively charged side-chains, in contrast with rheumatoid arthritis. We identified novel SLE signals in HLA Class I loci (HLA-A, HLA-B), and localized primary Class II signals to five residues in HLA-DRB1, HLA-DPB1, and HLA-DQB1. These findings provide insights about the mechanisms by which the risk residues interact with each other to produce autoantibodies and are involved in SLE pathophysiology. Author summary The Human leukocyte antigen (HLA) region is a key genetic factor conferring risk of systemic lupus erythematosus (SLE). In spite of multiple SLE association signals identified in the HLA region, only amino-acid residues within HLA-DRB1 have been specifically described previously. In this study, we performed an imputation-based analysis on individuals with East Asian ancestry, and characterized SLE risk within the HLA region for all involved independent genes (HLA-DRB1, HLA-DPB1, HLA-DQB1, HLA-A, and HLA-B). Furthermore, we identified a characteristic SLE risk residue signature as well as a pattern of specific nRNP and Ro/La autoantibody residues located in the peptide-binding grooves, suggesting their key involvement in autoantibody production.

Deep sequencing reveals a DAP1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus

Meta-analysis Followed by Replication Identifies Loci in or Near CDKN1B, TET3, CD80, DRAM1, and ARID5B As Associated with Systemic Lupus Erythematosus in Asians.

Meta-analysis of 208,370 East Asians identifies 113 genomic loci and yields new non-immune cell relevant biological insights for systemic lupus erythematosus

Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry

Identification of 38 Novel Loci for Systemic Lupus Erythematosus and Genetic Heterogeneity Between Ancestral Groups.

Identification of 38 Novel Loci for Systemic Lupus Erythematosus and Genetic Heterogeneity That May Underly Population Disparities in This Disease

Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries

Multi-ancestry and multi-trait genome-wide association meta-analyses inform clinical risk prediction for systemic lupus erythematosus

Biological Insights into Systemic Lupus Erythematosus Through an Immune Cell-Specific Transcriptome-Wide Association Study

High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry

Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus

Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus

Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus

High-throughput identification of functional regulatory SNPs in systemic lupus erythematosus

Preferential Association of a Functional Variant in Complement Receptor 2 with Antibodies to Double-Stranded DNA

Genome-wide Association Meta-Analysis in Chinese and European Individuals Identifies Ten New Loci Associated with Systemic Lupus Erythematosus

Whole-genome sequencing identifies rare missense variants of WNT16 and ERVW-1 causing the systemic lupus erythematosus

The genetics of systemic lupus erythematosus and implications for targeted therapy

Defining Mechanistic Links Between the Non-Coding Variant rs17673553 in CLEC16A and Lupus Susceptibility

Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus

Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians.